Specialities

Endocrinology

Clinical Neuroscience

MARCH 30, 2024

Perineural 5% dextrose versus corticosteroid injection in non-surgical carpal tunnel syndrom treatment

OZGE OCEK, DERYA GUNER

We aimed to investigate the difference of clinical and electrophysiological improvement between perineural corticosteroid injection therapy and perineural 5% dextrose injection therapy in carpal tunnel syndrome. Total of 92 wrists that were diagnosed as mild-to-moderate idiopathic CTS and completed their follow-up were included in our study. The severity of pain, symptom severity and functional status were assessed by visual analog scale.

Clinical Neuroscience

MARCH 30, 2024

Lightning strike‑induced cauda equina syndrome: a case report

AYSEGUL AKKAN SUZAN, BETUL OZENC, AYSE Gamze SAHIN, ZEKI ODABASI

Peripheral nerve injuries after being struck by lightning have been documented. Here, we report a case of cauda equina syndrome induced by lightning. A 27-year-old man presented with numbness, a burning sensation in the saddle region, and increased urinary urgency after being struck by lightning. He had absent Achilles reflexes and paresthesia in the saddle region upon neurological examination, and magnetic resonance imaging of the spine was normal.

Lege Artis Medicinae

MARCH 26, 2024

[Women and migrain ]

ÁFRA Judit

[Migraine is a headache disorder affecting 14% of general population, being even more prevalent (20%) among women in the 20–64 age group, who are actively working and are mainly at reproductive age. 18–25% of migrainous women have an attack related to menstrual cycle, 7% of them having an attack only at this period. Fluctuation of estrogen level may be responsible for these attacks, we can use NSAIDs, slowly acting triptans or progestin-only treatment as short-term prophylaxis. Hormonal contraception is not contraindicated in migraine. Combined (estrogen+progestin) treatment is proposed only in migraine without aura, but in case of more frequent and/or severe attacks or the appearence of an aura treatment should be stopped. In migraineurs with elevated risk of stroke combined hormonal contraception should be used with caution. In migraine with aura patients progestin-only contraception is possible. During pregnancy in 55–91% of migraineus women attacks disappear or are less severe. In most cases migraine with aura attacks occur during this period. Non-pharmacological treatments should be considered as first in the treatment off attacks, with consideration of risk/benefit ratio paracetamol, metamizol or triptans may be used. With the meno­pause in 2/3 of patients migraine gets better but because of the fluctuation of hormon levels it can be worse than before. Hor­mo­nal replacement therapy is not contraindicated in migrainous women but it can result in worsening of migraine. ]

Hypertension and nephrology

FEBRUARY 28, 2024

[Nationwide comprehensive health protection screening program in Hungary (2010–2020–2030 – MÁESZ) analysis of blood pressure and metabolic status]

BARNA István, DAIKI Tenno, HALMY Eszter, KÉKES Ede, DANKOVICS Gergely

[The “Comprehensive Health Protection Screening Program of Hungary 2010-2020-2030” (MÁESZ) (http://www.egeszsegprogram.eu) is the only complex screening program in Hungary, in which we aimed to map the health status of our country. Between 2010 and 2021, the screening program carried out in the truck was present in 2,406 locations nationwide and performed more than nine million screening tests for more than 280,000 citizens.]

Hypertension and nephrology

FEBRUARY 28, 2024

[Patients with diabetes, renal failure and perimenopausal hypertension]

ÁBRAHÁM György

[The determinants of cardiovascular (CV) morbidity and mortality is sympathetic overweight, which is the main risk factor for CVD. factors - hypertension (HT), diabetes mellitus (T2DM), renal function deterioration (CKD), dyslipidaemia and, in women, the perimenopausal status - significantly potentiates the adverse effects of diabetes, dyslipidemia, diabetes mellitus.]

Hypertension and nephrology

FEBRUARY 28, 2024

[Important effects of renin-angiotensin system and angiotensin receptor blockers. Focus on valsartan]

FARSANG Csaba

[Blockade of AT1-receptors causes arteriolar vasodilation leading to the decrease the total peripheral resistance (TPR), the aldosterone secretion, and the sodium reabsorption in renal tubuli with reduction of the intraglomerular pressure.]